NCT00358605

Brief Summary

This study will look at whether patients with OSAHS already successfully treated with nasal CPAP could successfully use an oral appliance as a short-term treatment alternative and whether patients who could use an oral appliance as an alternative would actually avail of its use, and to assess their preference in terms of treatment modality. The combination of therapies if tolerated, will allow greater flexibility of treatment and opportunity for ongoing compliance in circumstances where CPAP cannot be used.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2005

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2005

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

July 28, 2006

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 1, 2006

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
Last Updated

May 20, 2016

Status Verified

May 1, 2016

Enrollment Period

6.3 years

First QC Date

July 28, 2006

Last Update Submit

May 18, 2016

Conditions

Keywords

OSAHSOral ApplianceHypopnoea Syndrome

Outcome Measures

Primary Outcomes (1)

  • This study will compare apnea-hypopnea index (AHI) before and during oral appliance use.

Secondary Outcomes (4)

  • This study will compare Epworth Sleepiness Score, arousal index and sleep efficiency index between before and during oral appliance therapy.

  • It will compare the change in Sleep Apnea Quality of Life Index while on CPAP from baseline to while on Oral appliance.

  • Overall treatment compliance

  • Overall sleepiness score (subjective)

Interventions

See Detailed Description.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • stable on C-PAP for at least 3 months, and
  • Previous diagnostic polysomnography ithin 2 years, and
  • Pre-treatment AHI 10-30 ( mild-moderate sleep apnea), and
  • Compliance \> 4hrs per night, and
  • are willing and able to give informed consent

You may not qualify if:

  • AHI \>30, or
  • Oxygen Saturation \< 85% for \> 10% of study time during previous diagnostic PSG;
  • Or less than 8 teeth per jaw;
  • Or not enough teeth in good periodontal health to allow retention of the appliance;
  • Clinical evidence of severe tempero-mandibular joint dysfunction;
  • Operates heavy machinery or motor vehicle as part of job;
  • previous Motor Vehicle Crash assoc. with sleepiness;
  • or major cardiovascular morbidity;
  • or medically complicated or medically unstable.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vancouver Acute Sleep Disorder Program, UBC Hospital

Vancouver, British Columbia, Canada

Location

Related Publications (1)

  • Almeida FR, Mulgrew A, Ayas N, Tsuda H, Lowe AA, Fox N, Harrison S, Fleetham JA. Mandibular advancement splint as short-term alternative treatment in patients with obstructive sleep apnea already effectively treated with continuous positive airway pressure. J Clin Sleep Med. 2013 Apr 15;9(4):319-24. doi: 10.5664/jcsm.2576.

Related Links

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • John Fleetham, MD, FCRC

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2006

First Posted

August 1, 2006

Study Start

August 1, 2005

Primary Completion

December 1, 2011

Study Completion

December 1, 2011

Last Updated

May 20, 2016

Record last verified: 2016-05

Locations